• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞异质性及其对癌症细胞外基质和免疫景观重塑的影响。

Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.

机构信息

Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NS, United States.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, TX, United States.

出版信息

Matrix Biol. 2020 Sep;91-92:8-18. doi: 10.1016/j.matbio.2020.05.001. Epub 2020 May 19.

DOI:10.1016/j.matbio.2020.05.001
PMID:32442601
Abstract

Tumor progression is marked by dense collagenous matrix accumulations that dynamically reorganize to accommodate a growing and invasive tumor mass. Cancer-associated fibroblasts (CAFs) play an essential role in matrix remodeling and influence other processes in the tumor microenvironment, including angiogenesis, immunosuppression, and invasion. These findings have spawned efforts to elucidate CAF functionality at the single-cell level. Here, we will discuss how those efforts have impacted our understanding of the ways in which CAFs govern matrix remodeling and the influence of matrix remodeling on the development of an immunosuppressive tumor microenvironment.

摘要

肿瘤进展的标志是密集的胶原基质积累,这些基质会动态重组以适应不断生长和侵袭的肿瘤团块。癌相关成纤维细胞(CAF)在基质重塑中起着至关重要的作用,并影响肿瘤微环境中的其他过程,包括血管生成、免疫抑制和侵袭。这些发现促使人们努力在单细胞水平上阐明 CAF 的功能。在这里,我们将讨论这些努力如何影响我们对 CAF 控制基质重塑的方式的理解,以及基质重塑对免疫抑制性肿瘤微环境发展的影响。

相似文献

1
Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.成纤维细胞异质性及其对癌症细胞外基质和免疫景观重塑的影响。
Matrix Biol. 2020 Sep;91-92:8-18. doi: 10.1016/j.matbio.2020.05.001. Epub 2020 May 19.
2
Cancer associated fibroblast: Mediators of tumorigenesis.癌症相关成纤维细胞:肿瘤发生的介质。
Matrix Biol. 2020 Sep;91-92:19-34. doi: 10.1016/j.matbio.2020.05.004. Epub 2020 May 22.
3
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.肿瘤相关成纤维细胞异质性:免疫微环境重塑中不可忽视的因素。
Front Immunol. 2021 Jul 8;12:671595. doi: 10.3389/fimmu.2021.671595. eCollection 2021.
4
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.肿瘤微环境中癌症相关成纤维细胞的结构:解析其起源、异质性及其在癌症治疗耐药中的作用。
OMICS. 2020 Jun;24(6):314-339. doi: 10.1089/omi.2020.0023.
5
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.在放射治疗的背景下,癌症相关成纤维细胞与免疫细胞之间的相互作用。
Mol Carcinog. 2020 Jul;59(7):754-765. doi: 10.1002/mc.23205. Epub 2020 May 4.
6
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
7
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.成纤维细胞助力肿瘤微环境中的免疫逃逸。
Trends Cancer. 2019 Nov;5(11):704-723. doi: 10.1016/j.trecan.2019.09.009. Epub 2019 Oct 29.
8
Role of miRNAs in cell signaling of cancer associated fibroblasts.miRNAs 在癌症相关成纤维细胞细胞信号转导中的作用。
Int J Biochem Cell Biol. 2018 Aug;101:94-102. doi: 10.1016/j.biocel.2018.05.015. Epub 2018 May 25.
9
Modern views on the role of main components of stroma and tumor microinvironment in invasion, migration and metastasis.现代观点认为基质和肿瘤微环境的主要成分在侵袭、迁移和转移中的作用。
Exp Oncol. 2020 Dec;42(4):252-262. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-4.15401.
10
Stromal regulation of tumor-associated lymphatics.基质对肿瘤相关淋巴管的调控。
Adv Drug Deliv Rev. 2020;161-162:75-89. doi: 10.1016/j.addr.2020.08.001. Epub 2020 Aug 9.

引用本文的文献

1
Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer.PD-L1高表达非小细胞肺癌中的免疫治疗耐药性及治疗策略
Onco Targets Ther. 2025 Aug 29;18:953-966. doi: 10.2147/OTT.S539978. eCollection 2025.
2
Identification and validation of prognostic genes associated with mitochondrial nuclear genes in gastric cancer.胃癌中线粒体核基因相关预后基因的鉴定与验证
Clin Exp Med. 2025 Aug 31;25(1):309. doi: 10.1007/s10238-025-01844-3.
3
Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets.
肿瘤细胞外基质与调节性T细胞的生物力学:调节机制与潜在治疗靶点
Cell Commun Signal. 2025 Aug 21;23(1):375. doi: 10.1186/s12964-025-02380-z.
4
Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression.抑制ATM通过促进MHC-I表达增强三阴性乳腺癌的免疫原性。
Cell Death Dis. 2025 Aug 18;16(1):624. doi: 10.1038/s41419-025-07944-y.
5
Risk factors and management of lung cancer in idiopathic pulmonary fibrosis: A comprehensive review.特发性肺纤维化中肺癌的危险因素与管理:一项综述
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Mar 18;42(1):15604. doi: 10.36141/svdld.v42i1.15604.
6
Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer.棕榈酸积累激活成纤维细胞并促进结直肠癌中的基质硬度。
Cancer Res. 2025 May 15;85(10):1784-1802. doi: 10.1158/0008-5472.CAN-24-2892.
7
Tumor microenvironment and immunotherapy for triple-negative breast cancer.三阴性乳腺癌的肿瘤微环境与免疫治疗
Biomark Res. 2024 Dec 31;12(1):166. doi: 10.1186/s40364-024-00714-6.
8
Cold and hot tumors: from molecular mechanisms to targeted therapy.冷肿瘤和热肿瘤:从分子机制到靶向治疗。
Signal Transduct Target Ther. 2024 Oct 18;9(1):274. doi: 10.1038/s41392-024-01979-x.
9
Establishment of a tumor-associated fibroblast associated gene score based on scRNA-seq to predict prognosis in patients with triple-negative breast cancer.基于 scRNA-seq 的肿瘤相关成纤维细胞相关基因评分的建立,以预测三阴性乳腺癌患者的预后。
PLoS One. 2024 Oct 17;19(10):e0311801. doi: 10.1371/journal.pone.0311801. eCollection 2024.
10
Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challenges.纳米工程武装的溶瘤病毒驱动抗肿瘤反应:进展与挑战
MedComm (2020). 2024 Oct 10;5(10):e755. doi: 10.1002/mco2.755. eCollection 2024 Oct.